MAIA Biotechnology, Inc.
MAIA
$1.59
$0.00530.34%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.84M | 7.55M | 6.95M | 7.57M | 8.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.78M | 18.43M | 16.96M | 18.33M | 19.10M |
| Operating Income | -19.78M | -18.43M | -16.96M | -18.33M | -19.10M |
| Income Before Tax | -16.17M | -19.70M | -23.25M | -25.94M | -28.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.17 | -19.70 | -23.25 | -25.94 | -28.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.17M | -19.70M | -23.25M | -25.94M | -28.08M |
| EBIT | -19.78M | -18.43M | -16.96M | -18.33M | -19.10M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.60 | -0.82 | -1.12 | -1.38 | -1.62 |
| Normalized Basic EPS | -0.37 | -0.51 | -0.70 | -0.86 | -1.01 |
| EPS Diluted | -0.60 | -0.82 | -1.12 | -1.38 | -1.62 |
| Normalized Diluted EPS | -0.37 | -0.51 | -0.70 | -0.86 | -1.01 |
| Average Basic Shares Outstanding | 106.93M | 98.84M | 88.74M | 79.18M | 68.96M |
| Average Diluted Shares Outstanding | 106.93M | 98.84M | 88.74M | 79.18M | 68.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |